Dr. Elliot Marseille is Principal of the firm, Health Strategies International. He has
35 years of senior public health management and research experience and has
published widely on the cost-effectiveness of a range of global health diseases and
conditions, with a focus on HIV/AIDS. He is the Course Director for Cost-
Effectiveness Analysis in Medicine and Public Health, at UCSF. Dr. Marseille is a
leading expert on the economics of the emerging psychedelic-assisted therapies to
treat a range of psychiatric indications. He consults with the Multidisciplinary
Association for Psychedelic Studies (MAPS) in modeling the economics of
MDMA-assisted psychotherapy for the treatment of severe, treatment-resistant
PTSD; with the Usona Institute in analyzing the cost-effectiveness of psilocybin-
assisted therapy to treat major depression; and with John Hopkins University on
the cost-effectiveness of psilocybin-assisted therapy for tobacco cessation.
Additional interests include understanding the ethical foundations of cost-
effectiveness analysis and identifying sound criteria for judging cost-effectiveness.
555 59th Street
Oakland, CA 94609